Q1 2025 Omnicell Inc Earnings Call Transcript
Key Points
- Omnicell Inc (OMCL) reported a solid first quarter with total revenue of $270 million, an increase of $24 million from the first quarter of 2024.
- The company saw growth in its recurring revenue, driven by demand for its medication management platform and XT Amplify program.
- Non-GAAP earnings per share improved to $0.26 from $0.03 in the same period last year.
- Omnicell Inc (OMCL) continues to see strong customer interest in its long-term innovation roadmap, including the OmniSphere cloud-based platform.
- The company reported strong free cash flow of $10 million during the first quarter of 2025, with cash and cash equivalents increasing to $387 million.
- Omnicell Inc (OMCL) faced a GAAP loss of $0.15 per share in the first quarter of 2025, compared to a profit in the prior quarter.
- Non-GAAP gross margin decreased by 530 basis points from the prior quarter due to lower product revenue volumes and seasonal expenses.
- The company anticipates a $40 million impact on non-GAAP EBITDA for 2025 due to tariffs, particularly on China-based products.
- Omnicell Inc (OMCL) had to adjust its full-year 2025 non-GAAP EBITDA and earnings per share guidance due to the expected tariff impact.
- The company is facing challenges in its supply chain, with a significant portion of components sourced from China, leading to tariff exposure.
Good morning, my name is Carly and I will be your conference operator today. At this time, I would like to welcome everyone to the Omnicell first quarter 2025 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. (Operator Instructions) Thank you.
I would now like to turn the call over to Kathleen Nemeth, Senior Vice President, Investor Relations. Please go ahead.
Good morning and welcome to the Omnicell First Quarter 2025 financial results conference call. On the call with me today are Randall Lipps, Omnicell Chairman, President, CEO, and Founder; Nnamdi Njoku, Executive Vice President and Chief Operating Officer, and Nchacha Etta, Executive Vice President and Chief Financial Officer.
This call will contain certain forward-looking statements, including statements related to financial projections or performance or other statements regarding Omnicell
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
